These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 26236760)
1. Update on biomarkers in neuromyelitis optica. Melamed E; Levy M; Waters PJ; Sato DK; Bennett JL; John GR; Hooper DC; Saiz A; Bar-Or A; Kim HJ; Pandit L; Leite MI; Asgari N; Kissani N; Hintzen R; Marignier R; Jarius S; Marcelletti J; Smith TJ; Yeaman MR; Han MH; Aktas O; Apiwattanakul M; Banwell B; Bichuetti D; Broadley S; Cabre P; Chitnis T; De Seze J; Fujihara K; Greenberg B; Hellwig K; Iorio R; Jarius S; Klawiter E; Kleiter I; Lana-Peixoto M; Nakashima ; O'Connor K; Palace J; Paul F; Prayoonwiwat N; Ruprecht K; Stuve O; Tedder T; Tenembaum S; Garrahan JP; Aires B; van Herle K; van Pelt D; Villoslada P; Waubant E; Weinshenker B; Wingerchuk D; Würfel J; Zamvil S Neurol Neuroimmunol Neuroinflamm; 2015 Aug; 2(4):e134. PubMed ID: 26236760 [TBL] [Abstract][Full Text] [Related]
2. [The progress of research on the immune pathogenesis and biomarkers in optic neuritis related to neuromyelitis optica]. Liu WD; Yu MY; Jiang LB Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):228-233. PubMed ID: 30841690 [TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system]. Yang Y; Wu WP; Huang DH; Wu L Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372 [TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese. Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340 [TBL] [Abstract][Full Text] [Related]
12. Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder. Ringelstein M; Ayzenberg I; Harmel J; Lauenstein AS; Lensch E; Stögbauer F; Hellwig K; Ellrichmann G; Stettner M; Chan A; Hartung HP; Kieseier B; Gold R; Aktas O; Kleiter I JAMA Neurol; 2015 Jul; 72(7):756-63. PubMed ID: 25985228 [TBL] [Abstract][Full Text] [Related]
13. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link. Jarius S; Wildemann B Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872 [TBL] [Abstract][Full Text] [Related]
14. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963 [TBL] [Abstract][Full Text] [Related]
15. Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review. Pereira WL; Reiche EM; Kallaur AP; Kaimen-Maciel DR J Neurol Sci; 2015 Aug; 355(1-2):7-17. PubMed ID: 26050520 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Jarius S; Paul F; Franciotta D; Waters P; Zipp F; Hohlfeld R; Vincent A; Wildemann B Nat Clin Pract Neurol; 2008 Apr; 4(4):202-14. PubMed ID: 18334978 [TBL] [Abstract][Full Text] [Related]
17. Gamma-aminobutyric acid receptor agonists, aquaporin-4, and neuromyelitis optica: a potential link. Jarius S; Aktas O; Wildemann B Med Hypotheses; 2015 Nov; 85(5):628-30. PubMed ID: 26323247 [TBL] [Abstract][Full Text] [Related]
19. Incidence of AQP4-IgG seropositive neuromyelitis optica spectrum disorders in the Netherlands: About one in a million. Daniëlle van Pelt E; Wong YYM; Ketelslegers IA; Siepman DA; Hamann D; Hintzen RQ Mult Scler J Exp Transl Clin; 2016; 2():2055217315625652. PubMed ID: 28607712 [TBL] [Abstract][Full Text] [Related]